NCT07689760

Brief Summary

The goal of this observational study is to develop and validate an XAI based model that predicts HF events and identifies modifiable con-tributing factors, and to evaluate the added value of integrating high frequency smartwatch data compared to usual care in patients with heart failure. The main objectives of the study are:

  1. 1.To develop and validate an XAI based model that predicts HF events and identifies modifiable contributing factors, and to evaluate the added value of integrating high frequency smartwatch data compared to usual care. In the Netherlands usual care includes remote monitoring of heartrate, blood pressure, weight and symptoms.
  2. 2.To include insights of the smartwatch into activity patterns, impact on quality of life (KCCQ-12), and patient satisfaction with net promoter score (NPS).

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
95

participants targeted

Target at P50-P75 for all trials

Timeline
16mo left

Started Jul 2026

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress6%
Jul 2026Dec 2027

First Submitted

Initial submission to the registry

July 1, 2026

Completed
Same day until next milestone

Study Start

First participant enrolled

July 1, 2026

Completed
7 days until next milestone

First Posted

Study publicly available on registry

July 8, 2026

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 1, 2027

Last Updated

July 8, 2026

Status Verified

June 1, 2026

Enrollment Period

1.4 years

First QC Date

July 1, 2026

Last Update Submit

July 1, 2026

Conditions

Keywords

Heart FailureSmartwatchExplainable artificial intelligence

Outcome Measures

Primary Outcomes (1)

  • Heart failure (HF) event

    HF event is defined as: * Increase in diuretic treatment * Increase in NYHA class * Hospitalization caused by HF * Death caused by HF

    From enrollment to the end of follow-up at 6 months

Secondary Outcomes (3)

  • Activity patterns

    From enrollment to the end of follow-up at 6 months

  • Quality of life (QoL)

    Measured at baseline and at the end of follow-up at 6 months

  • Net promotor score (NPS)

    At the end of follow-up at 6 months

Study Arms (1)

Heart failure patients

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients will be selected after HF hospitalization at three hospitals: Medisch Spectrum Twente (MST), Hospital Group Twente (ZGT), and Deventer hospital.

You may qualify if:

  • Adult HF patients
  • NYHA class II, or NYHA III
  • Recent hospitalization for HF
  • Usual care with active participation in the telemonitoring program "Zorg Bij Jou" (ZBJ)
  • Possession of an iPhone 11 or newer and compatible with the study apps

You may not qualify if:

  • Lack of digital literacy or inability to use the device
  • Not capable to sign consent
  • Referral to hospice

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Heart Failure

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular Diseases

Central Study Contacts

Mark Schuuring, M.D., PhD., FESC, FEACVI, FHFA

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 1, 2026

First Posted

July 8, 2026

Study Start

July 1, 2026

Primary Completion (Estimated)

December 1, 2027

Study Completion (Estimated)

December 1, 2027

Last Updated

July 8, 2026

Record last verified: 2026-06

Data Sharing

IPD Sharing
Will not share

Personal medical data